|
Volumn 141, Issue 4, 2001, Pages 550-558
|
Testing the effectiveness of converting patients to long-acting antianginal medications: The Quality of Life in Angina Research Trial (QUART)
a,b c d d |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANGINA PECTORIS AGENT;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DILTIAZEM;
GLYCERYL TRINITRATE;
NITRATE;
ANGINA PECTORIS;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
OUTPATIENT;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SYMPTOMATOLOGY;
UNITED STATES;
|
EID: 0035094582
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1067/mhj.2001.112781 Document Type: Article |
Times cited : (28)
|
References (16)
|